DeepTarget Bio
DeepTarget Bio
  • Home
  • About
    • About Us
    • Leadership
    • Mission and Vision
    • Careers
  • Science
    • Pipeline
    • Research and Development
    • Technology
  • Contact Us
  • More
    • Home
    • About
      • About Us
      • Leadership
      • Mission and Vision
      • Careers
    • Science
      • Pipeline
      • Research and Development
      • Technology
    • Contact Us
  • Home
  • About
    • About Us
    • Leadership
    • Mission and Vision
    • Careers
  • Science
    • Pipeline
    • Research and Development
    • Technology
  • Contact Us

Pipeline

Current Pipelines

DTB-100 Series: Fibrosis

Target-specific anti-fibrosis therapy

DTB-100 Series comprises nanobody-based therapeutics designed to selectively target fibrosis-driving cells across multiple organs, including liver and lung.

DTB-200 Series: Fibrosis-Associated Cancer

  

DTB-300 Series: AI-powered biomarker development for early disease risk detection and diagnosis

  

  • Home
  • About Us
  • Leadership
  • Mission and Vision
  • Careers

DeepTarget Bio

Copyright © 2025 DeepTarget Bio - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept